Related Experiment Video

Updated: Oct 17, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

MEdical TReatment Optimization in cardiac rehabilitation (METRO study) : a French multicenter study

Bruno Pavy1, Marie-Christine Iliou2, Jean-Michel Guy3

  • 1Cardiac Rehabilitation Department. Loire VendéeOcéan Hospital, 44270 Machecoul, France.

Annales De Cardiologie Et D'Angeiologie
|October 12, 2021
PubMed

Insights

Optimizing medical treatment during cardiac rehabilitation (CR) for coronary artery disease (CAD) patients, including medication adjustments, significantly improves physical capacity. This enhances exercise tolerance and outcomes for heart patients.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Pharmacology

Background:

  • Cardiac rehabilitation (CR) is crucial for optimizing medical management in patients with coronary artery disease (CAD).
  • Effective CR programs aim to improve patient outcomes following acute coronary events or interventions.

Purpose of the Study:

  • To analyze medical management strategies employed during CR for CAD patients.
  • To evaluate the impact of these therapeutic modifications on patient outcomes and physical capacity.

Main Methods:

  • A prospective multicenter study included 1000 CAD patients within three months of an acute coronary syndrome (ACS), PCI, or CABG.
  • Medical treatments (beta-blockers, bradycardic agents, RAS inhibitors) were assessed at CR admission and discharge.
  • Patients were categorized into four groups based on medication adaptation: unchanged, beta-blockers/bradycardic agents, RAS inhibitors, or both.

Main Results:

  • Significant medication adaptations were observed: beta-blockers (32.1%), other bradycardic agents (9.5%), and RAS inhibitors (36.3%).
  • While initial resting heart rates varied, patients with medication adjustments showed greater heart rate reduction during exercise.
  • Combined physical training and therapeutic modifications led to similar exercise capacities (METs) across all four groups at discharge.

Conclusions:

  • The METRO study demonstrates that modifying medical treatments during CR can significantly enhance physical capacity in CAD patients.
  • Therapeutic interventions within CR programs contribute to improved exercise tolerance and overall patient outcomes.
Abstract

Keywords:
capacitéfonctionnellecardiac rehabilitationcoronary patientsentraînement physiqueexercise trainingmedical treatmentpatients coronariensphysical capacityréadaptationcardiaquetraitementmédical

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
66
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
58
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
56
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
66
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
70